CVM Updates
News about Animal Food, Drugs & Devices
These news releases provide the public with relevant and timely information about FDA and animal health. You can receive email updates by subscribing to our email distribution list.
Latest Update
April
- April 6, 2023 - Abbott Recalls the Readers used with the FreeStyle Libre, FreeStyle Libre 14 day, and FreeStyle Libre 2 Flash Glucose Monitoring Systems for Risk of Extreme Heat and Fire
FDA’s Center for Veterinary Medicine is sharing news of this recall to alert veterinarians who may be using this product. - April 5, 2023 - FDA Approves First Generic Flumethasone for Certain Anti-inflammatory Responsive Diseases in Cats, Dogs and Horses
- April 4, 2023 - FDA Releases Draft Guidance on Human User Safety in New Animal Drug Applications
March
- March 31, 2023 - FDA Approves First Generic Maropitant Citrate Tablets for Use in Dogs to Prevent Vomiting
- March 30, 2023 - FDA Approves First Generic Moxidectin Injectable Solution for the Treatment and Control of Parasites in Cattle
- March 29, 2023 - FDA Approves First Generic Cyclosporine Oral Solution for Cats for Treatment of Allergic Dermatitis
- March 28, 2023 - Department of Justice News - Couple Pleads Guilty to Smuggling $2 Million in Pesticides and Veterinary Drugs
- March 28, 2023 - Department of Justice News - Midwest Veterinary Supply Will Forfeit More Than $10 Million
- March 15, 2023 - Updated - FDA Announces Guidance for the Use of Published Literature to Support New Animal Drug Approvals (Español)
- March 9, 2023 - FDA Seeks $7.2 Billion to Protect and Advance Public Health by Enhancing Food Safety and Advancing Medical Product Availability
- March 6, 2023 - Updated - FDA Proposes Revisions to Guidance on Evaluating Safety of Antimicrobial Animal Drugs Based on Their Importance in Human Medicine
February
- February 28, 2023 - FDA Takes Action to Restrict Unlawful Import of Xylazine
- February 22, 2023 - FDA and EPA Announce Virtual Public Meeting and Comment Period on Modernizing their Approach to Oversight of Certain Products for Animals, including Flea and Tick Products
- February 17, 2023 - Tracey Forfa Announced as New Director of FDA’s Center for Veterinary Medicine
- February 15, 2023 - EPA and FDA to Seek Public Input on Modernizing Their Approach to Oversight of Certain Products
January
- January 27, 2023 - Updated - FDA Issues Draft Guidance that Consolidates and Updates Policies on Practices to Prevent Contamination of Animal Food from Unsafe Drug Carryover (Español)
- January 26, 2023 - FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward
- January 20, 2023 - Updated - FDA Cautions Horse Owners Not to Feed Recalled Lots of Top of the Rockies Alfalfa Cubes due to Reports of Illness and Death
- January 19, 2023 - Updated - FDA Announces Draft Guidance for Heartworm Disease Prevention Products for Dogs
- January 11, 2023 - FDA Approves First Generic Doramectin Topical Solution for Treatment of Certain Parasites in Cattle
- January 10, 2023 - FDA Issues the Foreign Supplier Verification Programs for Importers of Food for Humans and Animals Final Guidance
December
- December 23, 2022 - Department of Justice News - Collegeville Man Found Guilty for Scheme to Sell Fraudulent Canine Cancer-Curing Drugs to Pet Owners
- December 20, 2022 - FDA Approves First Injectable Pentosan for Osteoarthritis in Horses
- December 20, 2022 - FDA Issues Final Guidance on Best Practices for Convening a GRAS Panel
- December 19, 2022 - FDA and Federal Partners Issue Request for Information on the Regulation of Biotechnology
- December 17, 2022 - FDA Cautions Horse Owners Not to Feed Recalled Lots of Top of the Rockies Alfalfa Cubes due to Reports of Illness and Death
- December 16, 2022 - FDA Proposes Revisions to Guidance on Evaluating Safety of Antimicrobial Animal Drugs Based on Their Importance in Human Medicine
- December 14, 2022 - FDA Opens Registration for Virtual Public Meeting on FDA’s Role in the AAFCO Animal Feed Ingredient Definition Process
- December 13, 2022 - FDA Animal Drug Safety Communication: Micotil 300 Labeling Change (Español)
- December 13, 2022 - Updated - FDA Provides for More Treatments for Dogs and Cats to Qualify for Minor Use Status
- December 12, 2022 - FDA Releases Annual Summary Report on Antimicrobials Sold or Distributed in 2021 for Use in Food-Producing Animals
- December 9, 2022 - Department of Justice News - Thoroughbred Racehorse Trainer Jason Servis Pleads Guilty In Federal Doping Case
- December 8, 2022 - FDA Approves First Oral Treatment for Cats with Diabetes Mellitus
- December 7, 2022 - FDA Opens Second FY2023 Grant Funding Application Period for Animal Drugs for Minor Uses and Minor Species
November
- November 29, 2022 - FDA Announces Draft Guidance for Heartworm Disease Prevention Products for Dogs
- November 29, 2022 - FDA Launches Interactive Summary of Biomass-Adjusted Antimicrobial Sales Data in Food Animals
- November 18, 2022 - FDA Announces 2022 Public Meeting and Comment Period on Reauthorization of Animal Drug User Fee Program
- November 16, 2022 - FDA Releases Draft Amended Environmental Assessment for AquAdvantage Salmon and Announces Virtual Public Meeting
- November 16, 2022 - Department of Justice News - New York Veterinarian And Racehorse Trainers Sentenced To Prison In Federal Doping Case
- November 15, 2022 - FDA Conditionally Approves First Drug to Manage Acute Onset of Pancreatitis in Dogs
October
- October 20, 2022 - FDA Issues Final Guidance on Refusal of Inspection by a Foreign Food Establishment or Foreign Government
- October 19, 2022 - FDA Finalizes Guidance on Donor Eligibility and Manufacturing of Cellular Therapies for Animals
- Updated October 19, 2022 - FDA Announces 2022 Public Meeting and Comment Period on Reauthorization of Animal Generic Drug User Fee Program
- Updated October 18, 2022 - FDA Helps Improve Availability of Vetmedin, a Critical Heart Drug for Dogs, in the United States
- Updated October 18, 2022 - FDA Explains Revised Submission Process for U.S. Animal Feed Additive, Premix, and Compound Feed Facilities Interested in Exporting to China
- Updated October 12, 2022 - FDA Announces Virtual Listening Session on the Regulation of Animal Foods with Certain Types of Claims
- October 12, 2022 - FDA Announces 2022 Public Meeting and Comment Period on Reauthorization of Animal Generic Drug User Fee Program
September
- September 30, 2022 - FDA Reminds Human and Animal Food Facilities to Register or Renew Registration between October 1 and December 31, 2022
- September 29, 2022 - FDA Approves First Generic Spectinomycin Sulfate Injectable for Treatment of Bovine Respiratory Disease
- September 28, 2022 - FDA Approves Simplera Otic Solution to Treat Ear Infections in Dogs
- September 14, 2022 - FDA Provides for More Treatments for Dogs and Cats to Qualify for Minor Use Status
- September 8, 2022 - Department of Justice News - Horse Doping Seller Sentenced To 42 Months In Manhattan Federal Court
- September 7, 2022 - CVM Drug Safety Communication: Fluorouracil Products Used on People's Skin Can Cause Serious Reactions in Pets (Español)
August
- August 30, 2022 - FDA Announces Virtual Listening Session on the Regulation of Animal Foods with Certain Types of Claims
- August 11, 2022 - FDA Seeks Public Comment on Revised Guidance Documents Focused on Harmonizing Requirements for Anti-parasitic Drugs Used in Animals
- August 10, 2022 - FDA Releases FY 2020 Pesticide Residue Monitoring Report
- August 5, 2022 - FDA Cautions Pet Owners Not to Feed Certain Lots of Darwin’s Natural Pet Products Due to Salmonella
- August 1, 2022 - FDA Approves the First Generic Firocoxib Tablets for Horses (Español)
July
- July 29, 2022 - Department of Justice News - Illegal Pharmacy Operator Sentenced to Federal Prison
- July 27, 2022 - Department of Justice News - North Carolina Woman Pleads Guilty to Selling Unapproved Covid-19 Remedies
- July 27, 2022 - FDA Announces FY 2023 Animal Drug User Fee Rates for ADUFA and AGDUFA
- July 25, 2022 - FDA Withdraws Guidance on Indexing of Legally Marketed Unapproved New Animal Drugs for Minor Species (Español)
- July 22, 2022 - Food Facilities Invited to Join “How To” Webinar on Registration and Renewal as Biennial Food Facility Registration Period Approaches
- July 22, 2022 - FDA Details Optimized Approach for Regulatory Oversight Tools to Better Protect Public Health
- July 11, 2022 - Department of Justice News - Horse Doping Drug Supplier Sentenced To 11 Years In Prison
- July 6, 2022 - FDA Finalizes FSMA Guidance on Hazard Analysis and Preventive Controls for Animal Food
- July 5, 2022 - FDA Announces 2022 Public Meeting of the National Antimicrobial Resistance Monitoring System
June
- June 30, 2022 - FDA Delivers Progress Update on 5-Year Veterinary Stewardship Plan, Publishes Report about Antimicrobial Sales, Use, and Resistance Data in Animal Agriculture (Español)
- June 27, 2022 - FDA Announces Virtual Public Meeting on Advanced Manufacturing for Animal Drugs
- June 27, 2022 - FDA Announces Animal Biotechnology Webinar on Low-Risk Intentional Genomic Alterations in Animals for Food Use (Español)
- June 24, 2022 - FDA Recognizes JANAAC as an Accreditation Body Under FSMA- Accredited Third Party Certification Program
- June 22, 2022 - Department of Justice News - Amherst County Veterinarian Sentenced for Opioid Theft
- June 16, 2022 - FDA Conditionally Approves First Drug to Delay Onset of Congestive Heart Failure in Dogs (Español)
- June 10, 2022 - Updated - FDA Requests Public Comments on the Use of Antimicrobials in Companion Animals
- June 6, 2022 - FDA Announces Live Webinar on the Animal Drug Manufacturing System for Reporting Supply Chain Data
- June 6, 2022 - FDA Releases New Resource Page for Human and Animal Food Producers Affected by Flooding and Severe Weather Incidents
May
- May 31, 2022 - FDA Opens First FY2023 Grant Funding Application Period for Animal Drugs for Minor Uses and Minor Species
- May 26, 2022 - FDA Warns Four Companies for Illegally Selling CBD Products Intended for Use in Food-Producing Animals (Español)
- May 23, 2022 - FDA Shares New Report by Reagan-Udall Foundation on Establishing Public-Private Partnership to Collect and Analyze Antimicrobial Use Data from Food-Producing Animals
- May 11, 2022 - Department of Justice News - New York Racehorse Veterinarian And Standardbred Trainer Plead Guilty In Federal Doping Case
- May 9, 2022 - FDA Issues Draft Guidance that Consolidates and Updates Policies on Practices to Prevent Contamination of Animal Food from Unsafe Drug Carryover (Español)
- May 6, 2022 - Department of Justice News - Horse Doping Drug Seller Convicted In Manhattan Federal Court
- May 4, 2022 - FDA Issues Warning Letters to Companies Illegally Selling CBD and Delta-8 THC Products
April
- April 28, 2022 - FDA Issues the Accredited Third-Party Certification Program: Questions and Answers: Draft Guidance for Industry
- April 27, 2022 - FDA Issues Updated Guidance on Compliance and Date for Providing an Acceptable Unique Facility Identifier (DUNS number) for the Foreign Supplier Verification Programs
- April 26, 2022 - FDA alerts customers to voluntary recall of compounded drugs due to sterility issues by Drug Depot, LLC, dba APS Pharmacy
- April 21, 2022 - Department of Justice News - Lyndonville Woman Sentenced for Selling Misbranded Pet Medications
- April 20, 2022 - Department of Justice News - Supervisor at Long Island Drug Manufacturer Sentenced to Prison for Theft of Medical Products
- April 19, 2022 - FDA Releases NARMS Integrated Summary 2019
- April 19, 2022 - FDA Announces Draft Guidance for the Use of Published Literature to Support New Animal Drug Approvals (Español)
- April 13, 2022 - FDA Issues Final Guidance on Animal Drug Compounding from Bulk Drug Substances
March
- March 30, 2022 - FDA Approves New Combination Drug for Sedation in Dogs (Español)
- March 30, 2022 - Updated - FDA Announces Public Hearing on Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox
- March 28, 2022 - Updated - FDA Advises Companies Regarding Inadvertent Presence of Low Levels of Certain Genetically Engineered Canola Seeds
- March 28, 2022 - FDA Approves the First Generic Firocoxib Chewable Tablets for Dogs (Español)
- March 28, 2022 - Department of Justice News - Operator of Portland Animal Rescue Business Charged for Role in Wire Fraud Conspiracy, Illegally Dispensing Animal Drugs
- March 28, 2022 - Federal judge enters consent decree against New Jersey raw animal food manufacturer
- March 28, 2022 - FDA Seeks $8.4 Billion to Further Investments in Critical Public Health Modernization, Core Food and Medical Product Safety Programs
- March 11, 2022 - FDA Issues Guidance on Enforcement Discretion Policies for Certain FSMA Regulations
- March 7, 2022 - FDA Makes Low-Risk Determination for Marketing of Products from Genome-Edited Beef Cattle After Safety Review
- March 3, 2022 - Department of Justice News - Harness Trainer Christopher Oakes Sentenced To 3 Years In Federal Doping Case
- March 3, 2022 - FDA Urges Companies to be ’Recall Ready’ to Protect Public Health as Part of Final Guidance for Voluntary Recalls
February
- February 28, 2022 - FDA Veterinarians Contribute One Health Resource on Global Antiparasitic Resistance in Grazing Livestock (Español)
- February 18, 2022 - FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States
- February 15, 2022 - FDA Requests Public Comments on the Use of Antimicrobials in Companion Animals (Español)
- February 2, 2022 - Department of Justice News - Horse Doping Drug Supplier Convicted In Manhattan Federal Court
January
- January 25, 2022 - FDA Approves First Generic Tilmicosin Phosphate Aqueous Concentrate for Swine (Español)
- January 24, 2022 - Department of Justice News - Former Veterinarian Pleads Guilty to Drug Charges
- January 21, 2022 - FDA Announces Two Veterinary Antimicrobial Stewardship Funding Opportunities for FY 2022 (Español)
- January 20, 2022 - FDA Approves First Transdermal Buprenorphine for the Control of Post-Surgical Pain in Cats (Español)
- January 13, 2022 - FDA Approves Novel Treatment to Control Pain in Cats with Osteoarthritis, First Monoclonal Antibody Drug for Use in Any Animal Species
- January 12, 2022 - FDA Announces Public Hearing on Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox
- January 5, 2022 - Department of Justice News - Operator of Illegal Veterinary Pharmacy Pleads Guilty